Traws Pharma, Inc. — Director's Dealing 2025

Nov 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Traws Pharma, Inc. (TRAW)
CIK: 0001130598
Period of Report: 2025-11-21

Reporting Person: Leaman John Harold (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-11-21	Stock Option (right to purchase)	$2.31	A	12770	Acquired	2035-11-21	Common Stock (12770)	Direct

Footnotes

F1: These options vest over three years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.